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ABSTRACT 
Osteoporosis is a metabolic disease that affects individuals by causing bone 
quality to ultimately decrease, and therefore, makes these individuals more 
susceptible to fractures. Osteoporosis affects a large number of older individuals 
and causes high numbers of fractures that result in an increased morbidity. 
Osteoporosis, while considered a silent disease, presents a major health concern 
in our country as the number of elderly individuals dramatically increases.  There 
are three primary factors that have an effect on bone loss: gender, age, and 
obesity with hip and spinal fractures being the most predominant bones in 
humans that fracture. In prior studies, mice that have a functional mutation in the 
transcriptional co-regulator BrD2 gene were shown to become extremely obese 
but remained insulin responsive and showed a pattern of age and sex dependent 
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bone loss of their tibia.  This BrD2 lo mouse model therefore separated any 
observed effects on bone quality from loss in normal insulin homeostasis.  The 
goal of this study is to characterize the changes in the skeletal structure and 
bone mineral density of the L5 vertebrae.  The structural and mineral density 
properties of the entire L5 vertebrae of C57BL/6J wild type and BrD2 lo  
heterozygous male and female mice were determined by microcomputer 
topography analysis (μCT) at 3, 6, 9, 12 and 18 months of age. Skeleton 
morphological parameters acquired from the analysis included: bone volume 
fraction, trabecular thickness, trabecular number, trabecular separation, 
connectivity density, and structure model index. The female bone volume fraction 
was significantly lower than males, and the female BrD2 lo heterozygous 
population was significantly lower than male BrD2 lo heterozygous population.  
The female trabecular number was significantly lower than male groups starting 
at 6 months of age. Also, after 3 months of age, the female BrD2 lo heterozygous 
groups were significantly different from male BrD2 lo heterozygous groups. 
Connective density was significantly different for female BrD2 lo heterozygous 
groups compared to all other groups. The observed changes in trabecular 
architecture with our study have been confirmed by comparing them to similar 
studies of C57BL/6J mice. Age, sex, and obesity related changes in trabecular 
architecture at the L5 vertebrae for C57BL/6J mice show similar patterns to other 
bone sites. The female BrD2 lo heterozygous population had significantly 
pronounced levels of bone loss compared to wild type populations. BrD2 lo 
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heterozygosity and its associated obesity have significant effects on trabecular 
bone parameters and this effect is especially pronounced in female C57BL/6J 
mice.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
vi 
 
 
TABLE OF CONTENTS 
 
Title           i 
Reader’s Approval Page        ii   
Abstract           iii-v 
Table of Contents         vi 
List of Tables         vii 
List of Figures         viii 
List of Abbreviations         ix 
Introduction          1-11 
Methods           
 Animals         12 
 Preparation of Bones       12 
 μCT Scanning Protocol       12-14 
 Data Analysis        15 
Results          16-28 
Discussion           29-35 
References           36-38 
Vita           39 
 
 
 
 
 
 
vii 
 
 
LIST OF TABLES 
 
 
Table Title Page  
1 Incident Fractures by Fracture Type, Sex, Age, and Race 
for 2005. 
5 
2 Significant relationships between Age, Sex, Genotype & 
their interactions with trabecular architecture parameters 
for the entire population. 
24 
3 Age Related Changes in Murine Bone Structure. 35 
   
   
   
   
   
   
   
   
   
 
 
 
 
 
 
 
viii 
 
 
LIST OF FIGURES 
 
 
Figure Title Page  
1 
 
Representative 2D μCT images showing age related 
changes in trabecular architecture in the lumbar spine (L5) 
in male and female wild type C57BL/6J mice. 
18 
2 Representative 2D μCT images showing age related 
changes in trabecular architecture in the lumbar spine (L5) 
in male and female BrD2 heterozygous mice. 
19 
3 Representative 3D images showing age related changes 
in trabecular architecture in the lumbar spine (L5) in male 
and female wild type C57BL/6J mice. 
20 
4 Representative 3D images showing age related changes 
in trabecular architecture in the lumbar spine (L5) in male 
and female BrD2 heterozygous mice. 
21 
5 Height vs. Age by Sex & Genotype 25 
6 BV/TV vs. Age by Sex & Genotype 25 
7 Tb.N vs. Age by Sex & Genotype 26 
8 Tb.Th vs. Age by Sex & Genotype 26 
9 Th.Sp vs. Age by Sex & Genotype 27 
10 Conn.D vs. Age by Sex & Genotype 27 
11 SMI vs. Age by Sex & Genotype 28 
 
 
 
 
ix 
 
 
ABBREVIATIONS 
 
 
BMD  Bone Mineral Density 
BMI  Body Mass Index  
BrD2  Double Bromodomain Protein  
BV/TV  Bone Volume Fraction  
Conn.D Connectivity Density  
OPG  Osteoprotegerin  
PBS  Phosphate Buffered Saline  
PPARγ Peroxisome Proliferator Activated Receptor γ  
RANKL Receptor Activator of Nuclear Factor Kappa B Ligand 
ROI  Region of Interest  
SMI  Structure Model Index  
Tb.N  Trabecular Number 
Tb.Sp  Trabecular Separation  
Tb.Th  Trabecular Thickness  
 
 
 
 
 
 
 
1 
 
INTRODUCTION 
The human skeletal system serves many distinct functions. It is a 
structural system that works in conjunction with the muscular system in order to 
provide support and allow us to dynamically move our bodies. It serves to protect 
our vital organs and as a reserve for crucial ions within our body such as calcium 
and phosphorous. The bone provides the crucial stem cell niche in which the 
marrow system is contained that is critical for the production of blood and many 
immune cell lineages. Finally, the bone functions as an endocrine organ.   Bone 
is a living and dynamic tissue that is constantly being resorbed and rebuilt 
through the interaction of a multitude of cells. Many of these cells, such as 
osteoblasts and osteoclasts, are unique to the physiology of the bone, and their 
proper functioning is crucial in maintaining healthy bone quality and preventing 
bone disorders. However, there are diseases that directly and indirectly affect the 
quality of bone in humans, and many of these involve complex interactions 
between the bone cells and their external cellular environments.  
Osteoporosis is a metabolic bone disease that is characterized by an 
increase in skeletal fragility. The state of a bone’s health is defined by two terms, 
bone density and bone quality. Bone density refers to the grams of mineral 
content per unit area or volume, and bone quality refers to the underlying 
architectural structure and modeling of the bone itself. A decrease in either bone 
quality or density results in an increased susceptibility to bone fracture and 
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osteoporosis effects both quality and density.   Osteoporosis is a major health 
concern for the aging population (18). Bone growth in humans occurs mainly 
from ages 12 through 18. It is during this point that the bone has significant 
interaction between hormonal and environmental factors and a number of various 
genes that leads to an increase in skeletal growth and expansion.  Any condition 
that leads to alterations in bone formation, bone resorption or the hormonal and 
environmental conditions around the bone during this critical time period could 
lead to an overall decrease in peak bone mass. Subsequently, this will result in 
increased susceptibility to bone fracture and osteoporosis later in life (14). 
Furthermore, any condition that leads to a decrease in osteoblast activity, which 
leads to a decline in bone formation, or an increase in osteoclast activity, which 
leads to increased bone resorption, will ultimately predispose aging individuals to 
an increased risk of developing osteoporosis.  
Osteoporosis is a grave health concern in the United States, and the 
magnitude of its effect on society from both an economic and health care 
standpoint will only increase. It is estimated that the number of individuals that 
are currently osteoporotic is at about 10 million. This number is expected to 
increase to more than 14 million people in 2020. This is primarily due to an 
increase in the percentage of individuals over the age of 50. Estimates report that 
this age bracket is expected to increase by 60% by 2025 (3). By 2025, the 
incidence of fractures is expected to increase by 48% to greater than 3 million 
fractures incurring 25.3 billion dollars in additional health care related cost.  
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 At the present time, osteoporosis is responsible for more than 2.0 million 
fractures annually (Table 1).  71% of women over the age of 65 are at risk for 
developing osteoporosis. Studies estimate that one-third of 80,000 men who 
have a hip fracture will die within a year of sustaining their fracture. Thus, 
although osteoporosis is generally considered a silent disease, there are 
extremely high levels of mortality associated with the increased risk for fracture 
(4). It is crucial for medical research to pave the way to reduce the costs 
associated with osteoporosis related morbidities. Therefore, research must be 
directed toward discovering the underlying causes of bone loss, preventive ways 
to limit the incidence of osteoporosis in this country and new treatments to 
improve bone quality and density to patients that are already osteoporotic. 
It has been demonstrated that there is a significant difference in bone loss 
when comparing males and females in both animal and human studies. In murine 
studies, female mice have shown to have increased rates of bone turnover 
following ovarectomy compared to similarly aged male mice. This loss in bone 
mass is comparable to what is seen in adult women after loss of estrogen 
following menopause. Reduced estrogen levels ultimately lead to increased bone 
turnover, with resorption exceeding bone formation. Bone loss in mice following 
ovarectomy may in part be genetically regulated (2). Measures of trabecular 
bone parameters, such as BV/TV, trabecular number, and trabecular thickness 
allow for the quantification of changes in the trabecular architecture that occur 
with age in both animal and human studies. In mouse studies that have 
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compared the age related effects on trabecular architecture, female changes in 
trabecular structure that would indicate bone loss occur earlier and more rapidly 
when compared to male mice (9).  It is clear from murine studies that there is a 
significant difference in the rates of bone loss when comparing males and 
females, and this trend has also been established in human studies.  
 In human studies, females have significantly higher levels of bone loss 
compared to males and bone loss associated with aging is more marked in 
women when compared to men. However, multiple studies have shown that the 
predominant mechanism underlying bone loss in women is the gradual decline in 
estrogen production associated with menopause while aging is not the primary 
cause in women (2, 8).  Much like in the animal studies, human bone loss that is 
associated with sex can be primarily attributed to different hormonal profiles 
when comparing females and males. Specifically, the lowered production of 
estrogen as a result of menopause likely plays the greatest role in the significant 
differences in bone loss when comparing females to males. Due to the lower 
bone mass, especially after becoming menopausal, females are much more 
likely to develop osteoporosis and are more vulnerable to bone fractures (Table 
1).  
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Table 1: Incident Fractures by Fracture Type, Sex, Age, and Race for 2005*.  
 
 Table taken from Burge et al, 2007. 
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Differing sex is not the only thing that can have a significant effect on bone 
loss. Over time, natural aging processes ultimately lead to bone loss and an 
overall decrease in bone quality. A number of genetically inbred mouse strains 
have been developed as animal models to study bone loss and the development 
of osteoporosis. In studies that used conventional bone histomorphometry to 
analyze the effect of aging on male mice, it was determined that cancellous bone 
volume peaks around 12 months of age and can decrease as much as 50% by 
extreme old age (11). Studies of male C57BL/6J mice indicate that cancellous 
volume and trabecular number decrease and trabecular separation increases 
with advancing age. Trabecular bone volume peaks at an early age, and declines 
thereafter (2, 11).  
Although bone loss is not homogenous across various bone sites within 
mouse models, it is generally understood that age-related changes in vertebral, 
femoral, and tibial trabecular microarchitecture occur early and continue 
throughout life. Also, many aspects of trabecular architecture differ significantly 
when comparing male and female mice over time. Notably, age-related changes 
in females are much more pronounced. However, the most important thing 
learned from these murine studies is that the mouse model can serve as an ideal 
comparison to human studies of bone loss due to their relative similarities (2).  
 Mouse models are ideal for comparison to human studies due to their 
similarities in the nature of bone loss that occurs in both species and the 
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relatively short time scale of the aging process in mice.  Studies of bone loss in 
the C57BL/6J mouse have revealed a pattern of change that is remarkably 
similar to that observed in human aging. In human aging, cancellous bone 
volume, trabecular number, and trabecular thickness decrease, while trabecular 
separation increases. Compared to the C57BL/6J mouse, the only difference in 
these observed trends is that trabecular thickness does not appear to decrease 
with age. This suggests that bone loss in this particular mouse model is not 
associated with trabecular thinning (11).  
In some direct human studies that observed bone mineral density (BMD), 
which is used as an indirect indicator of osteoporosis in human clinical studies, it 
was indicated that bone loss was prevalent in the trabecular compartment of 
bones much more significantly than in the cortical compartment (22, 23). 
Specifically, there were significant relationships between age and bone mineral 
density in male and female scaphoid bones. Also, there was a high correlation in 
BMD loss between the calcaneus and talus, whereas, only a moderate 
correlation between the calcaneus and scaphoid bone (17). These studies would 
indicate that bone loss occurs primarily in the trabecular compartments in human 
bone, and that the rate of bone loss is not homogenous across various bone 
locations in the body. Bone loss is more prevalent in the trabecular space due to 
the increased surface area of the trabeculae compared to the cortical shell. 
Osteoblasts and osteoclasts line the surface of bones and thus, with a greater 
surface area in the trabecular compartment, there is more area for bone 
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remodeling to occur. Thus, with an imbalance of bone formation to bone 
resorption, bone loss in the trabecular compartment will be more prevalent (21). 
  Obesity is growing in epidemic proportions within the United States. 
People who are obese are the fastest growing group of individuals with 
osteoporosis in the country.  While previous theory was that a higher BMI would 
lead to increased mechanical loading, which increased bone remodeling to 
strengthen the bone, recent evidence suggests that obese individuals are more 
likely to sustain fractures (22, 23). Therefore, having a high BMI as a result of 
obesity is not protective for preventing fracture. Rather, obesity is contributing to 
bone fragility.   
The development of osteoporosis has been associated with an “obesity of 
the bone”, since with age, the fat content in the marrow space has been shown to 
increase.  The development of osteoporosis as a major co-morbidity of obesity 
has led to investigations between marrow fat formation and maintenance of 
trabecular bone (6). Adipocytes have shown to demonstrate endocrine functions, 
secreting adipokines and inflammatory cytokines. These secreted molecules 
have a significant effect on bone remodeling, either causing increased bone 
resorption or preventing bone formation. Through either pathway, they 
significantly change the status quo for bone remodeling, and thus, have a 
significant effect on quality of the bone.  
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Type II diabetes is also another co-morbidity that is often associated with 
obesity. Diabetes is a metabolic disorder that is associated with increased levels 
of blood sugar and the development of cellular insulin resistance. It has been 
shown that two key contributors to the development of “fatty bone” are insulin 
and the peroxisome proliferator activated receptor γ (PPARγ), a protein 
receptor/transcription factor that promotes insulin responsiveness, as well as the 
formation of fat.  Insulin responsiveness has a significant effect on osteoblasts 
and is a critical mediator of development of osteoblasts. After insulin binds to a 
receptor on the osteoblast, an insulin receptor substrate recruits and activates 
downstream signaling cascades. This signaling cascade is crucial to allow the 
osteoblast to fully mature from is precursor form (27). Diabetes-associated insulin 
resistance has also been implicated in other studies to cause a state of a chronic 
inflammation that increases bone loss by activating osteoclasts (6, 7, 19). Thus, 
in a diabetic state, insulin resistance leads to both increased turnover of the bone 
and decreased bone formation.  
PPARγ is a member of the PPAR subfamily of nuclear receptors and is a 
ligand activated transcription factor. This class of transcription factor has been 
shown to have an effect on both glucose metabolism and insulin sensitivity. 
Thus, it was initially considered a therapeutic target for potential diabetes drugs. 
However, recent studies have indicated that activation of PPARγ in the bone 
leads to the formation of adipocytes. Osteoblasts and adipocytes are both 
derived from mesenchymal stem cells (24, 25). Thus, as a result of PPARγ 
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activation in the bone, less osteoblast cells are formed and bone formation is 
negatively affected.  
Recent studies have shown that altered expression in the BrD2 gene 
(double bromodomain protein) is associated with obesity (26). The bromodomain 
is a 110 amino acid motif.  Bromodomain proteins serve as adaptor or scaffolding 
modules that recruit transcription regulatory factors to chromatin to form protein 
complexes that regulate gene transcription in response to signal transduction.  
Through numerous experiments it was elucidated that BrD2 normally co-
represses PPARγ and inhibits adipogenesis. By contrast, BrD2 knockdown 
activates adipogenesis and protects adipocytes from tumor necrosis factor-alpha 
induced insulin resistance, thereby decoupling inflammation from insulin 
resistance.  In subsequent preliminary studies our laboratory has shown that 
decreased expression of this gene is associated with the development of sex 
linked bone loss in the trabecular compartment of female mice.  The current 
studies expand on these findings by examining the trabecular structure of the 
vertebrae and test whether the loss of this gene’s activity leads to a more 
generalized systemic development of osteoporosis.  
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SPECIFIC AIMS 
In order to determine the relationship between the various bone cells and 
the development of obesity related osteoporosis, we used a unique BrD2 lo 
mouse developed by Dr. Gerald Denis at Boston University. These mice were 
engineered to express a mutated form of the protein that is functionally inactive.  
Using the haplotype of these mice which contain one functional active BrD2 gene 
studies in Dr. Denis’s laboratory showed that these mice become extremely 
obese but remain insulin-responsive.  Our previous studies showed that these 
mice also developed sex linked trabecular bone loss in their tibiae.  The goal of 
this study is to analyze the trabecular bone parameters for the L5 vertebrae of 
C57BL/6J wild type and BrD2 lo heterozygous populations of mice over a 15 
month period of aging.  
The hypothesis being tested is that the loss of BrD2 will lead to a 
generalized sex-linked osteoporosis that mimics the developed model of the 
human pathology.  If proven correct, this will be the first demonstration of a gene 
other than the estrogen receptor that is causally associated with bone loss in 
female animals.  Since BrD2 activity has been shown to be modified by small 
molecules it provides a “drugable” target.   Ultimately, this will allow for the 
development of targeted therapeutics for obesity induced osteoporosis.  
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METHODS 
Animals 
All wild type and mutant mice were bred by crossing BrD2 lo heterozygous mice 
and were maintained at Boston University Medical School Life Science Animal 
Laboratory.  Five ages were assessed:  3, 6, 9, 12 and 18 months (n = 4-10 per 
age per sex per genotype).  The variables observed investigating skeletal 
morphological parameters are thus: age, sex, and genotype.  The Boston 
University IACUC approved the protocol for this research study. 
Preparation of bones 
At the time of euthanasia the mice were weighed, and the right tibia and spinal 
column were collected. The surrounding soft tissues were then removed and the 
bones were fixed in 4% Paraformaldehyde (PFA) for one week at 4°C. 
Subsequently, they were transferred into a sterile pH 7.4 phosphate buffered 
saline solution and stored at 4°C until scans were completed.   
μCT Scanning Protocol 
Scans were carried out on a Scanco 40 microCT 40 instrument (SCANCO 
Medical AG, Brüttisellen Switzerland) located in the Orthopedics Developmental 
Laboratory in the Mechanical Engineering Department at the Boston University 
College of Engineering.  
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1) Bone length was determined by measuring the entire L5 vertebrae in the 
scout view. 
2) After acquiring a scout view, the entire L5 vertebrae was subsequently 
scanned. 
3) The specimens were scanned with a 8 μm isotropic voxel size ("high 
resolution setting") for the L5 vertebrae, voltage (E) set at 70 KVp, current (I) 
set at 114 μA, and an integration time of 200 ms using  μCT 40.  
4) Upon scanning, a region of interest (ROI) was defined for trabecular analysis.   
a) The ROI for trabecular analysis was defined as 100 slices distal to cranial 
epiphyseal plate and 100 slices proximal to caudal epiphyseal plate. End 
points for epiphyseal plates were defined as the first slice distal and 
proximal to be devoid of the cranial and caudal epiphyseal plate, 
respectively.  
i) The trabecular part of the vertebrae was manually delineated from the 
cortical bone.  
5) Contouring was performed using an automated script. 
a) The contours were then visually checked to make sure that they coincided 
with the specific areas of the bone we wanted to analyze. 
6) Image processing included Gaussian filtering and segmentation. 
a) The metaphyseal gray-scale images were processed using a low-pass 
filter (width of 0.8, support = 2).  
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b) The optimal threshold to be applied to the trabecular compartment in each 
group of mice was determined via an automated script.  
i) An ANOVA and subsequent Tukey-Kramer test was performed to 
determine which age groups were statistically different. 
ii) Based upon the results, it was determined that the male wild type 
population have a threshold of 207, the male BrD2 population have a 
threshold of 213, the 3 and18 month female age groups have a 
threshold of 204, and the 6, 9, and 12 month female age groups have 
a threshold of 217.  
7) All data acquired meet the minimum set of variables, and even surpass them, 
for reporting in accordance with the Guidelines for Bone Microstructure 
Assessment using μCT (1). 
a) Skeleton morphological parameters acquired from the trabecular analysis 
included: bone volume fraction (BV/TV, %), trabecular thickness (Tb.Th, 
mm), trabecular number (Tb.N, mm−1), trabecular separation (Tb.Sp, mm), 
connectivity density (Conn. D, 1/mm3), and structure model index (SMI). 
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Data Analysis 
All μCT skeletal morphological parameters were averaged and the 
standard deviations were calculated.  Three way ANOVA tests were performed 
on each skeletal morphological parameter.  A Tukey-Kramer post hoc test was 
used to identify which subsets under a variable were significantly different after 
three-way ANOVA calculated a P < 0.05 for a specific variable or set of variable 
interactions on a skeleton morphological parameter.  P < 0.05 was considered to 
be significant.  Data analysis was performed under JMP PRO 9.0.0. 
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RESULTS 
Significant Relationships between Age, Sex, & Genotype and trabecular 
architecture 
 
 Representative qualitative images of the 2D (Figures 1 and 2) and 3D 
(Figures 3 and 4) reconstructed volumes from those specimens that were closest 
to the mean values for each group are first presented.   
The graphic analysis of the micro CT parameters that showed statistical 
significance are presented in figures 5-11  and Table 2 provides a summary of 
statistically significant variables and inter-variable interactions from the ANOVA 
analysis. As the data indicates, vertebral bone height is significantly affected by 
both age and sex. When considered as a whole, the male population (3.65 ± 
0.02) had a significantly larger vertebral height than female population (3.57 ± 
0.02) (Figure 5).  
 For BV/TV, there are significant relationships between age, sex, and the 
sex and genotype interaction. Overall, the female population had significantly 
lower vertebral BV/TV values than the male population, 0.133 ± 0.005 versus 
0.173 ± 0.005, respectively with a greater decline being seen in BV/TV for the 
female population as they aged  (0.157 ± 0.009 to 0.091 ± 0.013) compared to 
the male population (0.184 ± 0.013 to 0.146 ± 0.013) . The overall decrease in 
total percent bone volume was a 41.8% and 20.7% decline for females and 
males, respectively.  As seen in figure 6, the bone loss is especially noticeable 
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for the female BrD2 lo population that had smaller BV/TV values across almost 
all ages that were examined, however, the statistical analysis did not reveal a 
significant age by sex interaction (P < 0.578). There was, however, a significant 
sex by genotype interaction.  Interestingly, there was no significant relationship 
comparing the male and female wild type populations, however, the only 
significant relationship was comparing the male and female BrD2 lo populations. 
The female BrD2 lo population (0.119 ± 0.007) had a significantly lower BV/TV 
value compared to the male BrD2 lo population (0.183 ± 0. 008).  
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Figure 1. Representative 2D μCT images showing age related changes in 
trabecular architecture in the lumbar spine (L5) in male and female wild 
type C57BL/6J mice. (A) Female 3 months, (B) Male 3 months, (C) Female 6 
months, (D) Male 6 months, (E) Female 9 months, (F) Male 9 months, (G) 
Female 12 months, (H) Male 12 months, (I) Female 18 months, (J) Male 18 
months.  
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Figure 2. Representative 2D μCT images showing age related changes in 
trabecular architecture in the lumbar spine (L5) in male and female BrD2 lo 
heterozygous mice. (A) Female 3 months, (B) Male 3 months, (C) Female 6 
months, (D) Male 6 months, (E) Female 9 months, (F) Male 9 months, (G) 
Female 12 months, (H) Male 12 months, (I) Female 18 months, (J) Male 18 
months  
20 
 
                     
Figure 3. Representative 3D images showing age related changes in 
trabecular architecture in the lumbar spine (L5) in male and female wild 
type C57BL/6J mice. (A) Female 3 months, (B) Male 3 months, (C) Female 6 
months, (D) Male 6 months, (E) Female 9 months, (F) Male 9 months, (G) 
Female 12 months, (H) Male 12 months, (I) Female 18 months, (J) Male 18 
months.  
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Figure 4. Representative 3D images showing age related changes in 
trabecular architecture in the lumbar spine (L5) in male and female BrD2 lo 
heterozygous mice. (A) Female 3 months, (B) Male 3 months, (C) Female 6 
months, (D) Male 6 months, (E) Female 9 months, (F) Male 9 months, (G) 
Female 12 months, (H) Male 12 months, (I) Female 18 months, (J) Male 18 
months.  
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The structural features of the vertebrae that were obtained from micro CT 
analysis are presented in figures 7-11.   Both age and sex had a statistically 
significant relationship for the trabecular number (Figure 7). Comparing the 
female and male populations, the female population (3.02 ± 0.05) had a 
significantly lower trabecular number then the male population (4.29 ± 0.06). For 
the age by sex interaction, it was noted that the 9, 12, and 18 month female 
populations were considered significantly different from all other groups, while 
the 6 month female group was only statistically similar to the male 18 month 
group while remaining significantly different from all other groups. Overall, the 
sex by genotype interaction revealed that the female wild type and BrD2 lo 
populations were not significantly different; however, they were statistically 
different from both the male wild type and BrD2 lo populations. According to the 
age by sex by genotype interaction, the 6, 9, 12 and 18 month female BrD2 lo 
groups were significantly lower than the male BrD2 lo age groups.  
 The female population (0.0541 ± 0.0006) had a significantly higher 
trabecular thickness value when compared to the male population (0.0483 ± 
0.0007). As indicated by the significant age by sex interaction and as can be 
seen from figure 8, all female age groups, except at 3 months, had a higher 
trabecular thickness when compared to their respective male counterparts. There 
was also a significant age by sex by genotype interaction.  
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 Trabecular separation also increased significantly overall with age (Figure 
9). From 3 months (0.22 ± 0.01) to 18 months (0.38 ± 0.01) we observed a 42% 
increase. The female population also had a significantly higher trabecular 
separation compared to the male population. Beyond 3 months, females had a 
significantly higher trabecular separation at all age points.  
 Connectivity density was considered to have a significant relationship in 
regards to both age and sex (Figure 10). Overall, the connectivity density 
decreased by 51% from the 3 month to 18 month age groups. The female 
population also had a significantly lower connectivity density when compared to 
the male population. With a significant sex by genotype interaction, it was noted 
that the female BrD2 lo population was considered significantly different from the 
female wild type, male BrD2 lo and male wild type populations.  The only 
significant interaction for SMI was for sex by genotype. The female BrD2lo 
population had a significantly higher SMI than the female wild type population 
(Figure11).  
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Table 2. Significant relationships between Age, Sex, Genotype & their 
interactions with trabecular architecture parameters for the entire 
population. 
                                                          
1
 Vertebrae Height = height of L5 vertebrae; BV/TV = Bone volume fraction. Ratio of bone volume 
over total volume assayed; Tb.N = Trabecular number. Measure of the average number of 
trabeculae per unit length; Tb.Th = Trabecular thickness. Mean thickness of trabeculae; Tb.Sp = 
Trabecular separation. Mean distance between the trabeculae; Conn.D = Connectivity density. A 
measure of the degree of connectivity of trabeculae; SMI = Structure model index. An indicator of 
the structure of trabeculae. SMI is 0 for parallel plates and it is 3 for cylindrical rods. 
2
 A value of p < 0.05 was determined to indicate a statistically significant relationship  
 
Age Sex Geno Age*Sex Sex*Geno Age*Geno Age*Sex*Geno 
Vertebrae 
Height
1
 P<0.0001
2
 P=0.013 - - - - - 
BV/TV P=0.0004 P<0.0001 - - P=0.0027 - - 
Tb.N P<0.0001 P<0.0001 - P=0.005 P=0.0034 - P=0.016 
Tb.Th - P<0.0001 - P=0.0007 - - P=0.04 
Tb.Sp P<0.0001 P<0.0001 - P<0.0001 - - - 
Conn.D P<0.0001 P<0.0001 - - P=0.002 - P=0.0006 
SMI - - - - P=0.0007 - - 
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Figure 5. Height vs. Age by Sex & Genotype (Age ± SD). 
 
Figure 6. BV/TV vs. Age by Sex & Genotype (Age ± SD) 
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Figure 7. Tb.N vs. Age by Sex & Genotype (Age ± SD). 
Figure 8. Tb.Th vs. Age by Sex & Genotype (Age ± SD). 
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Figure 9. Tb.Sp vs. Age by Sex & Genotype (Age ± SD). 
Figure 10. Conn.Density vs. Age by Sex & Genotype (Age ± SD). 
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Figure 11. SMI vs. Age by Sex & Genotype (Age ± SD). 
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DISCUSSION 
The vertebral bone height increased until 12 months of age and then 
maintained its height throughout the remainder of the experimental period that 
was examined at 18 months. These results can be compared to a study that 
showed that body weight increased until 12 months, and was stable until 24 
months of age in C57BL/6J male mice (11). This would suggest that the overall 
growth of the vertebrae in the C57BL/6J mice tracks that of overall body mass 
after which is remained constant. 
The results demonstrate that there are significant changes in the 
trabecular architecture in both the C57BL/6J wild type and BrD2 lo heterozygous 
mouse with age. Previous studies have shown that both cancellous bone and 
cortical bone undergo dramatic change during growth and aging in the male 
C57BL/6J mouse. Data suggest that skeletal changes in structure that occur 
during aging are similar to those that occur during human aging. Mouse models 
may be used as a model for comparison to the effects of aging in human bones, 
however, differences in body mass, skeletal structure, and life span may 
influence the dynamics of bone metabolism and how bone is lost with aging. 
Therefore, the model may be ideal for practical reasons, however, it is not a 
perfect model (11).  
The changes in BV/TV for our study resembled the results confirmed in 
previous studies. Table 3 shows that in a previous study of C57BL/6J mice, a 
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greater decline in BV/TV over lifetime was reported for females as opposed to 
males (52% versus 26%). Also, females were shown to have a lower BV/TV 
compared to males throughout their entire life. Significant age by sex related 
patterns indicated that patterns of age related change differed in males and 
females (9). Although there was no significant age by sex relationship, the sex by 
genotype relationship revealed that the female BrD2 lo population had a 
significantly lower BV/TV value compared to the male BrD2 lo population. It is 
likely that the unique genetic profile of the BrD2 lo heterozygous population 
within the female population had a significant effect on the trabecular 
architecture. Thus, as can be seen in figure 6, the female BrD2 lo BV/TV is 
significantly lower than the other populations of mice in our study.  
The results of other trabecular architecture parameters from our study 
were also confirmed by other previous studies. Notably, in a previous study that 
analyzed vertebral trabecular architecture, trabecular number peaked early in 
age, and saw a greater decline over the life of females compared to males. 
Trabecular number was also lower in females at all ages (9) (Table 3). In our 
study, trabecular number for females appears to decline at a faster rate early in 
age, and also have an overall greater decline throughout life. Also, female 
population groups had lower trabecular number values at all time points (Figure 
7). 
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 In a previous study, trabecular thickness was seen to increase in both 
male and female groups until 4 months in age, then plateaued for males and 
increased slightly in females with age (9). In our study, as demonstrated in figure 
8, it appears that both female groups have an increase in trabecular thickness 
until 9 months, while the male groups appear to plateau after three months. The 
female BrD2 lo population declines steadily after 9 months. It is possible that the 
typical form of bone remodeling in the BrD2 lo females is altered with age such 
that trabecular thickness no longer increases beyond a certain time point.  
In our study it was shown that connective density declined at a 
comparable rate between male and female populations and also that female 
groups had lower values for connective density at all age points (Figure 10). This 
was confirmed with a previous study of C57BL/6J mice where connective density 
declined similarly with age in both sexes and was lower in females compared to 
males at all time points (9) (Table 3).  
The trabecular parameters that are measured are interrelated, and thus, 
any fluctuation in one parameter has an effect on the other in some way. Insights 
into the relationships between these shifting parameters may provide potential 
explanation to the potential mechanisms of bone remodeling that occur in mouse 
models with age. Early decline in BV/TV is primarily caused by decrease in 
trabecular number and accompanied by an age related increase in trabecular 
thickness. Decline in trabecular number may result from a remodeling activity 
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that attempts to create a more efficient, organized structure according to 
predominant loading conditions (20). Increase in trabecular thickness may 
represent a compensatory thickening of the existing trabeculae as thinner ones 
are resorbed, and stress on existing trabeculae increases. Bone remodeling 
mechanisms may dictate that thinner trabeculae are no longer viable structures 
to maintain sufficient bone strength as aging progresses. Therefore, thinner 
trabeculae are preferentially removed to favor the formation, or increased 
thickening of already sufficiently thick trabeculae.  Alternatively, the increase in 
mean trabecular thickness may reflect the phenomenon that as thinner 
trabeculae are removed, the average thickness of remaining trabeculae 
increases (9). Therefore, an increase in trabecular thickness may not reveal a 
significant mechanism for bone remodeling, but rather, simply reflects a 
correlative relationship between two trabecular architectural parameters.  
Changes in trabecular architecture with age are inherently different at 
different sites throughout the body. As a dynamic and adaptable tissue, bone 
structure throughout the body changes in order to meet the physiological 
demands placed on it. Specifically, differing degrees of mechanical loading at 
various bone sites will cause a differential pattern of trabecular remodeling to 
occur in order to meet these physical demands. In other studies of the C57BL/6J 
mouse, age related deterioration in trabecular bone architecture was more 
severe in the metaphyseal region of long bones compared to vertebral bodies 
(9).  
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Age related changes in trabecular architecture followed different patterns 
in male and female mice. In our study specifically, trabecular number appears to 
decline more rapidly in early age (Figure 7), trabecular thickness appears to 
continue to increase after age 3 in female populations whereas in male 
populations the values plateau (Figure 8), and trabecular separation appears to 
increase more rapidly for female groups compared to male groups (Figure 9).   
The mechanisms for these changes in the absence of gonadal insufficiency are 
not completely understood. Decline in gonadal steroid production with age may 
contribute to changes that were observed (9). In all measured parameters except 
for SMI, there was a significant relationship due to sex. Therefore, male and 
female groups have significantly different trabecular architecture, and differing 
steroidal profiles between males and females may account for the observed 
differences.  
There are also genetic factors that can affect trabecular architecture, 
especially with age. Any type of signal that would affect the balance between 
bone resorption and bone formation will cause bone quality to either decrease or 
increase, respectively. With increased age, expression patterns of RANKL and 
OPG tend to favor osteoclast over osteoblast activity. Several factors may play a 
part in the increase in osteoclast over osteoblast activity with age including 
increased oxidative stress, decline in physical activity, alteration in body 
composition, and marrow adiposity (9).  
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Age related changes in trabecular architecture parameters may in part be 
related to the development of “obesity of the bone” in aging mice. A previous 
study reported that it is possible that age related accumulation of adipocytes in 
the bone marrow contributed to the decline in BV/TV in adulthood (9, 13). In the 
BrD2 lo heterozygous population, individuals may be more susceptible to 
adipocytes replacing the normal bone marrow tissue. Normally, BrD2 lo co-
represses PPARγ and inhibits adipogenesis.  By contrast, BrD2 lo knockdown 
activates adipogenesis. Therefore, BrD2 lo heterozygous mice may be more 
susceptible to the replacement of normal bone marrow with adipocytes, and as a 
result, bone degeneration may be more pronounced with increasing age.  
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Table 3: Age Related Changes in Murine Bone Structure*.  
 
 
 Table taken from Glatt et al, 2007.  
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